Research
The Lakers' 25% Leap: Why Sports Scarcity, Not Earnings, Is Setting the New Asset Floor
The Lakers' record valuation is a repricing of scarce live attention, league-level media rights and the limited supply of franchises.
Research
Deep-dive stock research and institutional-grade analysis.
Research
The SEC's Vanishing Vote: Why Crypto's Regulatory Breakthrough Is Still a Delay Trade
The SEC canceled its crypto rulemaking meeting, exposing the gap between regulatory momentum and durable legal certainty.
Research
The 3.4% Hold: Why Tame CPI Makes the Fed's September Decision Harder, Not Easier
July CPI eased to 3.4%, but the real market signal is a steeper curve: a Fed hold may delay a hike without delivering duration relief.
Research
Asia's $25 Billion Exit: Why the Bank Rotation Is a Repricing, Not a Risk-Off Trade
Foreign investors pulled $25.48 billion from Asia in July, but the concentrated exit from AI hardware is masking a bank-led repricing of regional growth.
Research
The $500 Billion U.S. Drug Factory: Why Tariff-Driven Pharma Capex Is a Margin Trade, Not a Manufacturing Boom
Drugmakers are pledging $500 billion for U.S. capacity. The contrarian read: this is a margin and tariff-avoidance trade, not proof every plant will pay back.
Research
The Three-to-One Exit: Why Bank Refinancing, Not Redemptions, Is Repricing Private Credit
Private credit's real stress test is moving from fund gates to borrower exits as cheaper syndicated loans pull the strongest credits back toward banks.
Research
The $36.6 Billion Yen Rescue: Why Joint Intervention Buys Time, Not a New Exchange-Rate Regime
The first joint US-Japan yen intervention since 2011 is a backstop against disorderly markets, but it buys BOJ time rather than creating a durable FX floor.
Research
The 86% Beat Rate: Why Record S&P Profits Still Leave Equities Exposed
A record 86% of S&P 500 companies are beating EPS estimates, but the rally's next test is not profit collapse. It is the market's rising burden of proof.
Research
The 44,000-Hire Warning: Why Friday's Payrolls May Not Bring a Fed Pivot
ADP's 44,000-job print says hiring is cooling, but sticky service costs and low layoffs mean weak payrolls may not deliver the rate relief markets expect.
Research
Novo's Better Forecast: Why a Higher 2026 Guide Cannot Repair the Obesity Franchise
Novo Nordisk raised its 2026 outlook, but investors sold the stock. The market is pricing a pipeline gap, not disputing one quarter's execution.
Research
Brazil's 14% Threshold: Why the Fourth Cut Will Not End the Carry Trade
Brazil's expected fourth rate cut is not a dovish victory. The real test is whether fiscal risk keeps the Selic and the carry trade structurally high.
Research
Seoul's 18% Rebound: Why Korea's Leveraged Washout Is Not a Bottom
South Korea's record rebound shows forced selling has eased, not that the market has found a durable floor. The next trade is about structure, not speed.